BRAF and lung adenocarcinoma: Durable Response to the Combination of Atezolizumab With Platinum-Based Chemotherapy in an Untreated Non-Smoking Lung Adenocarcinoma Patient With <i>BRAF</i> V600E Mutation: A Case Report.